Media Library

Common Presenting Factors for NSCLC

Common Presenting Factors for NSCLC

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon provides an overview of the most common presenting clinical features in adults with non-small cell lung cancer (NSCLC). View Video ›

Shifts in Lung Cancer Treatment

Shifts in Lung Cancer Treatment

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon reviews how certain drugs can change the landscape for treating patients with lung cancer. View Video ›

A Look at PD-1 and PD-L1 Inhibitors

A Look at PD-1 and PD-L1 Inhibitors

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon discusses the use of PD-1 and PD-L1 inhibitors in patients with lung cancer. View Video ›

ALK Gene Rearrangement and PD-L1 Expression

ALK Gene Rearrangement and PD-L1 Expression

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon does not believe there is much value in utilizing PD-L1 inhibitors for pateints with ALK gene rearrangement. View Video ›

Differences in NSCLC Patient Populations

Differences in NSCLC Patient Populations

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon speaks about how differences in patient populations with lung cancer can make it difficult to interpret and act on data. View Video ›

Choosing the Right Therapy for Patients with NSCLC

Choosing the Right Therapy for Patients with NSCLC

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon shares an anecdote about an interesting NSCLC case from his practice. View Video ›

Immunotherapies and Lung Cancer

Immunotherapies and Lung Cancer

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon explains how he discusses immunotherapies with patients. View Video ›

My Practice: Roles and Responsibilities

My Practice: Roles and Responsibilities

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon describes how staff at his practice interacts with patients. View Video ›

Challenges in Managing Toxicities

Challenges in Managing Toxicities

By Edward Garon, MD

Lung Cancer, Video

Dr. Edward Garon believes it's important to recognize that agents without efficacy are not beneficial to the patient despite low toxicity. View Video ›

Beth Faiman, PhD, APRN-BC, AOCN, Nominated for LLS Woman of the Year

Beth Faiman, PhD, APRN-BC, AOCN, Nominated for LLS Woman of the Year

By Beth Faiman, PhD, APRN-BC, AOCN

Original Research, Audiocast

In a recent interview with The Oncology Nurse-APN/PA (TON), Beth Faiman, PhD, APRN-BC, AOCN, Nurse Practitioner, Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, and Editor-in-Chief of TON discussed her recent acceptance of a nomination for the Leukemia & Lymphoma Society (LLS) Woman of the Year award. View Video ›

Page 10 of 12

3
4
5
6
7
8
9
10
11
12

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive:

TON Print Edition

TON Weekly e‑Newsletter

I have reviewed and consent to the terms of TON's Privacy Policy, and TON has my permission to retain my information in its database, and to forward pertinent communications to me.